drugset
drugset / Trial / NCT06575374

Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell

NCT06575374 ↗

Phase 2 Recruiting 36 enrolled M.D. Anderson Cancer Center
NaSingle-groupOpen-labelPrevention

Summary

The goal of this clinical research study is to learn if a drug called Letermovir can help to prevent CMV reactivation.

Timeline

Start
2024-12-12
Primary completion
2026-08-01
Completion
2027-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Letermovir Small molecule — Oral

Indications

No indication recorded.